Trademark: 79302141
Word
ELZYVAR
Status
Registered
Status Code
700
Status Date
Tuesday, August 3, 2021
Serial Number
79302141
Registration Number
6436604
Registration Date
Tuesday, August 3, 2021
Mark Type
4000
Filing Date
Wednesday, November 18, 2020
Published for Opposition
Tuesday, May 18, 2021

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Events
Jul 23, 2023
Change Of Name/Address Rec'd From Ib
Oct 3, 2021
Notification Processed By Ib
Sep 15, 2021
Final Disposition Notice Sent To Ib
Sep 15, 2021
Final Disposition Processed
Sep 2, 2021
Grant Of Protection Created, To Be Sent To Ib
Aug 3, 2021
Registered-Principal Register
May 18, 2021
Published For Opposition
May 17, 2021
Notification Processed By Ib
Apr 28, 2021
Notification Of Possible Opposition Sent To Ib
Apr 28, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 28, 2021
Notice Of Publication
Apr 12, 2021
Approved For Pub - Principal Register
Mar 30, 2021
Assigned To Examiner
Jan 23, 2021
Application Filing Receipt Mailed
Jan 19, 2021
New Application Office Supplied Data Entered
Jan 15, 2021
Limitation From Original Application Entered
Jan 14, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24